Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC
Clinical trial NCT02064491 · COMPLETED
Trial details
- NCT number
- NCT02064491
- Sponsor
- Finnish Lung Cancer Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.